BK Polyomavirus Micro-RNAs: Time Course and Clinical Relevance in Kidney Transplant Recipients

• Published in: Viruses Vol. 13; no. 2; p. 351
• Main Authors: Demey, Baptiste, Descamps, Véronique, Presne, Claire, Helle, Francois, Francois, Catherine, Duverlie, Gilles, Castelain, Sandrine, Brochot, Etienne
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 23.02.2021; MDPI
• Subjects: BKPyV; Deoxyribonucleic acid; DNA; Immunosuppressive agents; Infections; Kidney transplantation; Kidney transplants; Life Sciences; microRNA; MicroRNAs; miRNA; Plasma; Polymerase chain reaction; polyomavirus BK; Replication; Software; Urine; Viral infections; France; United States > US; BKPyV; microRNA; polyomavirus BK; kidney transplantation
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v13020351

Kidney transplant recipients (KTRs) are exposed to a high risk of BK polyomavirus (BKPyV) replication, which in turn may lead to graft loss. Although the microRNAs (miRNAs) bkv-miR-B1-3p and bkv-miR-B1-5p are produced during the viral cycle, their putative value as markers of viral replication has yet to be established. In KTRs, the clinical relevance of the changes over time in BKPyV miRNA levels has not been determined. In a retrospective study, we analyzed 186 urine samples and 120 plasma samples collected from 67 KTRs during the first year post-transplantation. Using a reproducible, standardized, quantitative RT-PCR assay, we measured the levels of bkv-miR-B1-3p and bkv-miR-B1-5p (relative to the BKPyV DNA load). Detection of the two miRNAs had low diagnostic value for identifying patients with DNAemia or for predicting DNAuria during follow-up. Seven of the 14 KTRs with a sustained BKPyV infection within the first year post-transplantation showed a progressive reduction in the DNA load and then a rapid disappearance of the miRNAs. DNA and miRNA loads were stable in the other seven KTRs. After the DNA-based diagnosis of BKPyV infection in KTRs, bkv-miR-B1-3p and bkv-miR-B1-5p levels in the urine might be valuable markers for viral replication monitoring and thus might help physicians to avoid an excessive reduction in the immunosuppressive regimen.